Since it was set up 150 years ago, Carl Reiner has dedicated itself to the construction and development of state-of-the-art surgical instruments and equipment. Carl Reiner recently took the plunge into the global market with the first microprocessor-controlled unit for jet ventilation. The special feature of this innovative procedure is that it enables patients to be ventilated without a separate air tube.
A broken bone is always an unpleasant experience. Understandably enough, therefore, after successful bone healing one would be glad to simply forget about surgical procedures and orthopaedic implants once and for all. BRI.Tech enables patients to do so by making a second operation unnecessary: the biodegradable implants they develop do not need to be removed later on. The whole secret lies in using elements which are naturally present in the human body and will in due course dissolve without further intervention.
The Linz-based company NP Life Science Technologies is developing and manufacturing neural-like implants that support the body in regenerating traumatised peripheral nerves. The novel implant developed by the startup replicates the acellular structure of a nerve by many small, parallely aligned channels. Hence, the growth of regenerating nervous cells between the nervous ends is instantly guided and regeneration is accelerated. The polymer’s particular chemical properties facilitate the adaptation of the mechanical properties to the requirements of the nervous tissue and the covalent bonding of growth-stimulating substances. The degradation products are non-toxic, neutral substances that are removed via metabolic processes.
Patients suffering from acute or chronic lung diseases are unable to sufficiently clear the carbon dioxide generated by metabolic processes in their bodies by exhaling it via the lung. CCORE, a spinoff of the Medical University of Vienna, is developing new methods for minimally invasive blood purification. The company is developing a solution to prevent lung injury caused by invasive ventilation methods or even avoid, or largely reduce, the need for invasive ventilation.
Angel Valve Vienna is dedicated to the development of sophisticated treatment concepts for mitral valve repair. With the current lead product, the Mitral Butterfly® implant, the company focuses on the minimally invasive intervention of mitral regurgitation, a condition that affects 2-3% of the world´s population.
AFreeze uses cryotechnology for the treatment of cardiac arrhythmia. The company’s technology is a device that shock-freezes tissue in the left atrium via a catheter, thereby eliminating all three possible mechanisms of arterial fibrillation.
EMCOOLS Medical Cooling Systems develops and markets novel non-invasive cooling devices to benefit neurologic outcomes after ischaemic events such as myocardial infarction, stroke and cardiac arrest. In pre-hospital and in-hospital settings, EMCOOLS products deliver a perfect synergy of ease of use and best-in-class product performance.
Miracor Medical Systems is commercialising a new technology for improving outcomes for heart attack patients. Using an approach called Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO), the method seeks to improve blood flow in the heart tissue and improve overall heart function after a severe heart attack.